Only 20% of ovarian cancers are detected early, mostly because there are seldom symptoms that don’t mimic common bladder, bowel or gastrointestinal issues. However, a recent Penn Today article noted the FDA approval of Cytalux, an imaging drug for ovarian cancer that aims to improve early detection, and therefore survival rates.
FDA Approves ‘Glowing Tumor’ Imaging Drug
The drug is attracted to ovarian cancer tissue and illuminates under fluorescent light to pinpoint cancer.
Dec 9, 2021
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More